FDA interested in details of industry OTC anticaries biological testing plan -- FDA's Bowen.
This article was originally published in The Rose Sheet
FDA INTERESTED IN DETAILED INDUSTRY PLAN FOR ANTICARIES BIOLOGICAL TESTING as the agency considers industry's request to postpone the effective date of the anticaries final monograph from Oct. 7, 1996 to Oct. 7, 1997. OTC Division Director Debra Bowen expressed interest in the information at an April 3 "OTC feedback" meeting with the oral care task force formed jointly by the Nonprescription Drug Manufacturers Association and the Cosmetic, Toiletry, and Fragrance Association.
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review